Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy of a delightful breeze and shiny sun hovering over the peaceful Pharmalot campus this morning. Our shortest person has left for the local schoolhouse, another short one has left for remunerative activities, and our official mascot has settled down after barking at passersby. This leaves us all alone to forage for interesting items and speak with interesting people. Meanwhile, here is the usual menu of tidbits. Hope your day goes well and do keep us in mind when something interesting pops …

A $270 million settlement between the state of Oklahoma and Purdue Pharma, which was praised last week as an innovative way to help combat opioid addiction, is facing bipartisan criticism from state lawmakers who say the attorney general overstepped his authority, the Associated Press writes. Lawmakers say money from the first-of-its-kind settlement should have gone to the state treasury, where legislators would have determined how it was spent. They also grumbled that Attorney General Mike Hunter kept them in the dark about settlement talks.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy